LBNL scientific analysis spinout Newomics has been backed by Berkeley Catalyst Fund to develop a testing platform initially targeting medical and biotech applications.
Newomics, a US-based scientific analysis technology spinout of Lawrence Berkeley National Laboratory (LBNL), closed an oversubscribed $3.9m series A round today led by VC firm Photon Fund and backed by Berkeley Catalyst Fund.
LBNL is a US government-owned laboratory hosted by University of California (UC) Berkeley, which launched Berkeley Catalyst Fund to support LBNL spinouts as well as those from UC Berkeley and San Francisco.
Founded in 2014, Newomics is developing a testing platform primarily intended for medical…
